Bristol Myers sues AstraZeneca over cancer-treatment patents

Bristol Myers Squibb Co (BMY.N), in a lawsuit made public on Friday, said AstraZeneca's (AZN.L) cancer treatment Imfinzi violates patents related to its blockbuster cancer drug Opdivo.